Advertisement

Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions

Published:December 18, 2021DOI:https://doi.org/10.1016/j.neurom.2021.10.006

      Abstract

      Objectives

      SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT (Consolidated Standards of Reporting Trials) statements have been shown to improve the quality of reporting of trial protocols and randomized controlled trials. Extensions to the SPIRIT and CONSORT statements specific to certain interventions have the potential to address methodological considerations that would otherwise be overlooked. The aim of this protocol is to describe the methods to develop reporting guidelines for clinical trial protocols and reports of implantable neurostimulation devices.

      Materials and Methods

      The SPIRIT-iNeurostim and CONSORT-iNeurostim extensions will be developed through a staged consensus process involving literature review and expert consultation. The initial list of candidate items will be informed by findings from previous systematic reviews and published protocols and clinical trials of implantable neurostimulation devices. The candidate items will be included in a two-round Delphi survey. In the first round, participants will be invited to vote on the importance of each item and to suggest additional relevant items. In the second round, participants will be invited to re-score the items considering feedback received and the suggested additional items. A consensus meeting will then take place to discuss the results of the Delphi survey and reach consensus on the items to include in the extensions.

      Discussion

      Development of the SPIRIT-iNeurostim and CONSORT-iNeurostim extensions has the potential to lead to improvements and increase in transparency of the reporting of clinical trial protocols and reports of implantable neurostimulation devices.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. The CONSORT Statement. Accessed November 9, 2021. CONSORT. http://www.consort-statement.org.

        • Ranganathan P.
        The CONSORT statement and its impact on quality of reporting of trials.
        Perspect Clin Res. 2019; 10: 145-147
      2. SPIRIT. Accessed November 9, 2021. CONSORT. http://www.consort-statement.org/resources/spirit.

        • MacPherson H.
        • Altman D.G.
        • Hammerschlag R.
        • et al.
        Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement.
        PLoS Med. 2010; 7e1000261
        • Liu X.
        • Cruz Rivera S.
        • Moher D.
        • Calvert M.J.
        • Denniston A.K.
        • SPIRIT-AI and CONSORT-AI Working Group
        Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
        Nat Med. 2020; 26: 1364-1374
        • Cruz Rivera S.
        • Liu X.
        • Chan A.W.
        • et al.
        Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
        Nat Med. 2020; 26: 1351-1363
        • Eldabe S.
        • Gulve A.
        • Thomson S.
        • et al.
        Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness? (TRIAL-STIM study): study protocol for a randomised controlled trial.
        Trials. 2018; 19: 633
        • Al-Kaisy A.
        • Royds J.
        • Palmisani S.
        • et al.
        Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol.
        Trials. 2020; 21: 111
        • Eldabe S.
        • Duarte R.V.
        • Gulve A.
        • et al.
        Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial.
        Pain. 2020; 161: 2820-2829
        • Mekhail N.
        • Levy R.M.
        • Deer T.R.
        • et al.
        Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a doubleblind, randomised, controlled trial.
        Lancet Neurol. 2020; 19: 123-134
        • Kapural L.
        • Yu C.
        • Doust M.W.
        • et al.
        Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial.
        Anesthesiology. 2015; 123: 851-860
        • Deer T.R.
        • Levy R.M.
        • Kramer J.
        • et al.
        Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial.
        Pain. 2017; 158: 669-681
        • Duarte R.V.
        • McNicol E.
        • Colloca L.
        • Taylor R.S.
        • North R.B.
        • Eldabe S.
        Randomized placebo-/sham-controlled trials of spinal cord stimulation: a systematic review and methodological appraisal.
        Neuromodulation. 2020; 23: 10-18
        • McNicol E.
        • Ferguson M.
        • Bungay K.
        • et al.
        Systematic review of research methods and reporting quality of randomized clinical trials of spinal cord stimulation for pain.
        J Pain. 2021; 22: 127-142
        • Katz N.
        • Dworkin R.H.
        • North R.
        • et al.
        Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations.
        Pain. 2021; 162: 1935-1956
        • Moher D.
        • Schulz K.F.
        • Simera I.
        • Altman D.G.
        Guidance for developers of health research reporting guidelines.
        PLoS Med. 2010; 7e1000217
        • Williamson P.R.
        • Altman D.G.
        • Bagley H.
        • et al.
        The COMET Handbook: version 1.0.
        Trials. 2017; 18: 280

      Comments